Journal of Biomedicine and Biochemistry (JBB) is committed to maintaining transparency, integrity, and trust in the editorial and publication process. All participants in the publication process—including authors, reviewers, editors, and editorial board members—must disclose any relationships or interests that could be perceived as influencing the content, review, or decision-making related to a manuscript.

Definition of Conflict of Interest

A conflict of interest (COI) exists when professional judgment concerning a primary interest (such as the validity or interpretation of research) may be influenced by a secondary interest. Conflicts may be financial, personal, academic, professional, or institutional, whether actual, potential, or perceived.

Authors’ Responsibilities
 
Authors are required to disclose all potential conflicts of interest that could influence their work, including but not limited to:
 
•⁠  ⁠Financial relationships (e.g., grants, funding, employment, consultancies, stock ownership, honoraria, patents)
•⁠  ⁠Personal or professional relationships
•⁠  ⁠Institutional affiliations or funding sources
•⁠  ⁠Any other interests that may be perceived to affect the objectivity of the research
 
All disclosures must be clearly stated in a Conflict of Interest Statement within the manuscript. If no conflicts exist, authors must explicitly declare:
 
⁠“The authors declare no conflict of interest.”
 
Failure to disclose relevant conflicts may result in rejection, correction, or retraction of the article.
 

Reviewers’ Responsibilities

Reviewers must disclose any potential conflicts of interest before agreeing to review a manuscript. Reviewers should decline the review if they:

•⁠  ⁠Have a personal, professional, or financial relationship with the authors
•⁠  ⁠Have collaborated with the authors recently
•⁠  ⁠Have competing interests that could compromise objectivity

Reviewers are expected to treat all manuscripts confidentially and to evaluate them solely on scientific merit.

Editors’ Responsibilities

Editors and editorial board members must recuse themselves from handling manuscripts in which they have a conflict of interest, including:

•⁠  ⁠Authorship or recent collaboration with the authors
•⁠  ⁠Institutional affiliation with the authors
•⁠  ⁠Financial or personal interests related to the manuscript

In such cases, the manuscript will be reassigned to an independent editor to ensure an unbiased evaluation.

Management of Conflicts

When a conflict of interest is disclosed, the journal will:

•⁠  ⁠Evaluate the relevance and significance of the disclosed interest
•⁠  ⁠Take appropriate measures to ensure a fair and independent review process
•⁠  ⁠Publish conflict of interest statements alongside accepted articles when applicable

All decisions are made in accordance with COPE and ICMJE guidelines, and editorial decisions are based solely on academic merit.

Undisclosed Conflicts

If an undisclosed conflict of interest is identified after publication, the journal may take corrective action, including:

•⁠  ⁠Publishing a correction or disclosure statement
•⁠  ⁠Issuing an expression of concern
•⁠  ⁠Retraction of the article in serious cases

Commitment to Ethical Publishing

The Journal of Biomedicine and Biochemistry adheres to international standards of publication ethics and transparency and requires full cooperation from all parties to uphold the credibility of the scholarly record.